Showing all posts written by Adam Gilbert

Adam Gilbert
Adam Gilbert
With over a dozen years of experience, Mr. Gilbert is regularly sought for strategic United States and international patent procurement, patent portfolio strategy and management, competitive landscape analysis including legal opinions and recommendations for design-arounds, due diligence, IP audits, technology agreements including licenses, non-disclosure agreements, and IP transfer agreements.
Equipped with an army-knife of knowledge, Mr. Gilbert represents clients in a wide range of technologies including medical devices, semiconductor fabrication, food science and processing, microelectromechanical systems (MEMS), chemical processes, injection molding, nanotechnology, energy storage, mechanical systems, and more. In the medical device field, he has worked extensively with emerging and large companies in the cardiovascular, neuromodulation, tissue ablation, medicine-device combination, ophthalmic, implant, and prosthetic fields, particularly using catheter-based technologies in a variety of body lumens and cavities. His technical experience in both chemical engineering and medtech yields a unique perspective in the strategic development and analysis of global patent portfolios.
In addition to representing medical device venture capital firms and emerging companies in high-stakes investments, Mr. Gilbert has also been involved in several successful acquisitions in the medtech field, representing both acquiring companies and targets.
You can follow him on Twitter, @PatentAG, where he comments about interesting IPR filings, recent cases, where you can find him at conferences, giving webinars, and recruiting, and, most popularly, showcasing random U.S. patents as large round patent numbers are approached.
Based in Orange County, Mr. Gilbert represents clients in several states and on five continents.
Prior to law school, Mr. Gilbert worked as a photolithography process engineer after a rotation program, gaining broad experience in all aspects of semiconductor fabrication and general manufacturing practices. He also has work experience in water purification systems and methods and environmental remediation.

PTAB Institutes Inter Partes Review of Medtronic “Jervis” Patent

On June 11, 2019, the U.S. Patent and Trademark Office Patent Trial and Appeal Board (PTAB) instituted inter partes review (IPR) of U.S. Patent No. 6,306,141, assigned to Medtronic Vascular, Inc.  The Decision instituted the IPR based on